Zacks Research Forecasts Medifast’s Q1 Earnings (NYSE:MED)

Medifast, Inc. (NYSE:MED) – Equities research analysts at Zacks Research upped their Q1 2025 earnings per share estimates for Medifast in a research report issued to clients and investors on Monday, March 10th. Zacks Research analyst R. Department now expects that the specialty retailer will post earnings of ($0.07) per share for the quarter, up from their prior estimate of ($0.10). The consensus estimate for Medifast’s current full-year earnings is $0.51 per share. Zacks Research also issued estimates for Medifast’s Q4 2025 earnings at $0.53 EPS, FY2025 earnings at $1.04 EPS, Q3 2026 earnings at $0.39 EPS and Q4 2026 earnings at $0.49 EPS.

Medifast (NYSE:MED) last issued its earnings results on Tuesday, February 18th. The specialty retailer reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.26. Medifast had a return on equity of 10.64% and a net margin of 0.35%. The business had revenue of $119.00 million during the quarter, compared to analysts’ expectations of $114.25 million.

Separately, DA Davidson dropped their price objective on shares of Medifast from $17.00 to $16.50 and set a “neutral” rating on the stock in a research note on Wednesday, February 19th.

Medifast Price Performance

Shares of Medifast stock opened at $13.86 on Thursday. The stock has a market cap of $151.56 million, a price-to-earnings ratio of 76.98 and a beta of 1.13. The firm’s 50-day moving average is $15.25 and its two-hundred day moving average is $17.43. Medifast has a 1 year low of $13.57 and a 1 year high of $39.14.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in MED. Wells Fargo & Company MN boosted its position in Medifast by 23.5% during the fourth quarter. Wells Fargo & Company MN now owns 6,459 shares of the specialty retailer’s stock valued at $114,000 after purchasing an additional 1,227 shares in the last quarter. Quarry LP boosted its holdings in shares of Medifast by 148.6% in the 3rd quarter. Quarry LP now owns 6,629 shares of the specialty retailer’s stock valued at $127,000 after buying an additional 3,962 shares in the last quarter. Public Employees Retirement System of Ohio grew its position in shares of Medifast by 1,161.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 9,766 shares of the specialty retailer’s stock worth $187,000 after buying an additional 8,992 shares during the last quarter. State of Wyoming grew its position in shares of Medifast by 286.1% in the 4th quarter. State of Wyoming now owns 11,312 shares of the specialty retailer’s stock worth $199,000 after buying an additional 8,382 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its stake in shares of Medifast by 2,308.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer’s stock worth $202,000 after acquiring an additional 10,967 shares in the last quarter. 95.51% of the stock is owned by institutional investors.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.